Reported Jan 27, 2016 · Terminated

Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods…

Pine Pharmaceuticals, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Pine Pharmaceuticals, LLC · 100 Colvin Woods Pkwy Suite 300 · Tonawanda, NY · 14150-6974

Is this the product you have?

  • Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
Lot codes and dates
  • 412 of 412 codes

    • Lot #: 1956@2
    • exp. 2/2/2016
    • 1954@1
    • exp. 2/2/2016
    • 1958@3
    • exp. 2/2/2016
    • 1943@2
    • exp. 2/1/2016
    • 1942@1
    • exp. 2/1/2016
    • 1944@3
    • exp. 2/1/2016
    • 1938@1
    • exp. 1/31/2016
    • 1939@2
    • exp. 1/31/2016
    • 1931@1
    • exp. 1/28/2016
    • 1932@2
    • exp. 1/28/2016
    • 1935@3
    • exp. 1/28/2016
    • 1925@1
    • exp. 1/27/2016
    • 1927@2
    • exp. 1/27/2016
    • 1928@3
    • exp. 1/27/2016
    • 1913@3
    • exp. 1/26/2016
    • 1917@4
    • exp. 1/26/2016
    • 1911@1
    • exp. 1/26/2016
    • 1921@6
    • exp. 1/26/2016
    • 1906@3
    • exp. 1/25/2016
    • 1903@1
    • exp. 1/25/2016
    • 1904@2
    • exp. 1/25/2016
    • 1899@3
    • exp. 1/24/2016
    • 1896@2
    • exp. 1/24/2016
    • 1895@1
    • exp. 1/24/2016
    • 1886@2
    • exp. 1/21/2016
    • 1893@5
    • exp. 1/21/2016
    • 1890@4
    • exp. 1/21/2016
    • 1885@1
    • exp. 1/21/2016
    • 1888@3
    • exp. 1/21/2016
    • 1879@5
    • exp. 1/20/2016
Amount recalled
N/A

This recall covers 4 products

The agency filed one notice per product. You are reading one of them; the other 3 are below.

Where it was sold

  • Nationwide
  • PR

Why it was recalled

Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Pine Pharmaceuticals, LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 22, 2017 · Data as of Sep 19, 5:50 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.